Mirae Asset Global Investments Co., Ltd. - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 208 filers reported holding MIRATI THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,383,000
+20.2%
7,818
+9.7%
0.00%
+33.3%
Q2 2021$1,151,000
+6.5%
7,126
+12.9%
0.00%
-25.0%
Q1 2021$1,081,000
-15.9%
6,310
+7.8%
0.00%
-20.0%
Q4 2020$1,285,000
+83.0%
5,851
+38.4%
0.01%
+66.7%
Q3 2020$702,000
-6.1%
4,227
-35.5%
0.00%
-40.0%
Q2 2020$748,000
+70.4%
6,549
+14.7%
0.01%
+66.7%
Q1 2020$439,000
-24.3%
5,710
+26.9%
0.00%
-25.0%
Q4 2019$580,000
+71.6%
4,499
+3.8%
0.00%
+100.0%
Q3 2019$338,0004,3360.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders